Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03803423 · ClinicalTrials.gov registry record · NA
Dissemination of the Donor Application: Utilizing Social Media to Identify Potential Live Organ Donors
A NA study of End Stage Renal Disease and End Stage Liver DIsease, sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- NA
- Development phase
- 1,000
- Enrollment target
- 6
- Study locations
NCT03803423: Recruiting NA study of End Stage Renal Disease and End Stage Liver DIsease, sponsored by Johns Hopkins University.
NCT03803423 is a NA study of End Stage Renal Disease and End Stage Liver DIsease that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 1,000 participants, above the 822-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (22% higher). The trial reports 6 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03803423, a NA study of End Stage Renal Disease and End Stage Liver DIsease, is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,000 participants
- Enrollment target
- 6
- Study locations
Study Summary
This study utilizes a web-based application to help patients on the organ transplant waitlist communicate patient's need for a living donor via social media and provide interested potential donors the opportunity to engage with the evaluation process.
Primary Outcome
Number of potential live donors that come forward to the transplant center on behalf of the participant.
Conditions Studied
Interventions
- OTHER The Donor App
Study Locations (6)
California
- Scripps Green Hospital - San Diego
Connecticut
- Yale University - New Haven
Illinois
- Rush University Medical Center - Chicago
Maine
- Maine Medical Center - Portland
Maryland
- The Johns Hopkins Hospital - Baltimore
Missouri
- Washington University in St. Louis - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2017-11-27 |
| Est. Completion | 2026-11-27 |
| Phase | NA |
What NCT03803423 shows while recruiting
NCT03803423 is an interventional study that assigns participants to a tested intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, above the 822-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (22% higher).
The record links to 2 conditions, with End Stage Renal Disease appearing as the primary indexed condition, and to 1 intervention - of which The Donor App is the first listed.
NCT03803423 lists 6 locations in 6 states (California, Connecticut, Illinois).
Frequently Asked Questions
What is clinical trial NCT03803423 about?
NCT03803423 is a clinical study titled "Dissemination of the Donor Application: Utilizing Social Media to Identify Potential Live Organ Donors". This study utilizes a web-based application to help patients on the organ transplant waitlist communicate patient's need for a living donor via social media and provide interested potential donors the opportunity to engage with the evaluation process.
What is the current status of trial NCT03803423?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,000 participants. The study started on 2017-11-27. Estimated completion is 2026-11-27.
What conditions does trial NCT03803423 study?
This clinical trial studies the following conditions: End Stage Renal Disease, End Stage Liver DIsease.
What interventions are being tested in trial NCT03803423?
The interventions under investigation include: The Donor App (OTHER).
Who is sponsoring clinical trial NCT03803423?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03803423 being conducted?
This trial has 6 study locations across California, Connecticut, Illinois, Maine, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for End Stage Renal Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03803423's enrollment target sits among peer trials
1,000 6th of 86 higher than 81 of 86 other End Stage Renal Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other End Stage Renal Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
RECRUITING · NA
-
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
RECRUITING · NA
-
Shared Decision Making for Kidney Transplant Candidates to Plan for an Organ Offer Decision
RECRUITING · NA
-
Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients
RECRUITING · NA
-
CAPABLE Transplant
RECRUITING · NA
-
Intravascular Ultrasound in Patients With End-stage Renal Disease on Dialysis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI